Volume | 79,234 |
|
|||||
News | - | ||||||
Day High | 21.94 | Low High |
|||||
Day Low | 21.57 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Fulgent Genetics Inc | FLGT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
21.66 | 21.57 | 21.94 | 21.79 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
2,363 | 79,234 | $ 21.77 | $ 1,724,725 | - | 19.88 - 44.09 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
13:48:10 | 3 | $ 21.62 | USD |
Fulgent Genetics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
644.84M | 29.78M | - | 289.21M | -167.83M | -5.63 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Fulgent Genetics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical FLGT Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 20.50 | 22.68 | 20.50 | 21.49 | 219,708 | 1.13 | 5.51% |
1 Month | 21.01 | 22.68 | 19.88 | 20.79 | 184,178 | 0.62 | 2.95% |
3 Months | 25.62 | 25.71 | 19.88 | 22.31 | 222,980 | -3.99 | -15.57% |
6 Months | 26.04 | 30.68 | 19.88 | 24.67 | 202,210 | -4.41 | -16.94% |
1 Year | 34.53 | 44.09 | 19.88 | 29.10 | 215,473 | -12.90 | -37.36% |
3 Years | 73.12 | 112.00 | 19.88 | 59.29 | 346,912 | -51.49 | -70.42% |
5 Years | 5.65 | 189.8899 | 4.712 | 59.58 | 510,979 | 15.98 | 282.83% |
Fulgent Genetics Description
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign. |